Related Experiment Video
Updated: Mar 20, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets
1Department of Hepatopancreatobiliary and Splenic Medicine , Affiliated Hospital, Logistics University of People's Armed Police Force , Tianjin , People's Republic of China.
Abstract:
Hepatic macrophages account for the largest non-parenchymal cell population in the liver. Recent studies have found that hepatic macrophages have different functions in different stages of experimental liver fibrosis. Some studies found that there are different types of hepatic macrophages in the liver, although others have suggested that hepatic macrophages could switch to different phenotypes in different environments. Many studies demonstrated that while hepatic macrophages promoted fibrosis through the recruitment of proinflammatory immune cells, and the secretion of proinflammatory cytokines and chemokines in the early stages, these also promoted the resolution of hepatic fibrosis through the secretion of matrix metalloproteinases in the late stages. This article will review the current role played by hepatic macrophages in liver fibrosis and the potential therapeutic targets that modulate hepatic macrophages.
Insights
Hepatic macrophages play dual roles in liver fibrosis, promoting it early on and resolving it later. Understanding these roles may reveal new therapeutic targets for liver fibrosis.
Area of Science:
- Immunology
- Hepatology
- Cell Biology
Background:
- Hepatic macrophages are the most abundant non-parenchymal cells in the liver.
- Their function in liver fibrosis is complex and stage-dependent.
- Evidence suggests hepatic macrophages may exist as distinct types or exhibit phenotypic plasticity.
Purpose of the Study:
- To review the current understanding of hepatic macrophage roles in liver fibrosis.
- To explore potential therapeutic strategies targeting hepatic macrophages in liver fibrosis.
Main Methods:
- Literature review of studies on hepatic macrophages in experimental liver fibrosis.
- Analysis of macrophage functions in early and late stages of fibrosis.
- Identification of molecular mechanisms involved in macrophage-mediated fibrosis promotion and resolution.
Main Results:
- Hepatic macrophages promote liver fibrosis in early stages by recruiting inflammatory cells and secreting pro-inflammatory mediators.
- In late stages, hepatic macrophages contribute to fibrosis resolution by secreting matrix metalloproteinases.
- The dynamic functions suggest a potential for therapeutic modulation.
Conclusions:
- Hepatic macrophages exhibit stage-specific, dichotomous roles in liver fibrosis.
- Targeting hepatic macrophage phenotypes and functions presents a promising therapeutic avenue for liver fibrosis treatment.
More Related Videos
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
10:15Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
Published on: May 9, 2025
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Inflammation
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test